Severe Acute Blood Loss Anemia in Jehovah's Witnesses Undergoing Cardiac Surgery: Single Academic Center Experience.
J Cardiothorac Vasc Anesth
; 37(4): 513-518, 2023 04.
Article
in En
| MEDLINE
| ID: mdl-36435723
ABSTRACT
OBJECTIVE:
To determine the effect of severe acute blood loss anemia (ABLA) on postoperative outcomes in Jehovah's Witness (JW) patients undergoing cardiac surgery.DESIGN:
This was a retrospective cohort study of adult JW patients undergoing cardiac surgery requiring cardiopulmonary bypass (CPB) between January 1998 and December 2018 at Barnes-Jewish Hospital in St. Louis, Missouri.SETTING:
At a single tertiary academic center.PARTICIPANTS:
Patients who were JWs undergoing cardiac surgery requiring CPB.INTERVENTIONS:
Patients were divided into the following 2 groups JW patients who developed severe ABLA (defined as postoperative hematocrit level <21), and patients who did not develop severe ABLA. MEASUREMENTS AND MAINRESULTS:
A total of 48 JW patients who underwent cardiac surgery between 2008 and 2018 were identified. Of these patients, 9 (18.8%) developed postoperative severe ABLA, and 39 (81.3%) did not. Severe ABLA was associated with increased postoperative mortality at 30-days, 90-days, and 1-year postoperatively, and a trend toward increased hospital length of stay.CONCLUSIONS:
Severe ABLA after cardiac surgery was associated with higher mortality and a trend toward increased hospital length of stay among JW patients. More data are required to confirm the findings.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Jehovah's Witnesses
/
Cardiac Surgical Procedures
/
Anemia
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
J Cardiothorac Vasc Anesth
Journal subject:
ANESTESIOLOGIA
/
CARDIOLOGIA
Year:
2023
Document type:
Article